Mandarin Oriental Hotel
776 Boylston Street
Boston, MA
05/12/2010
7:45 AM - 9:30 AM
The Chamber is pleased to partner with Ernst & Young to present the findings of "Beyond Borders 2010 - Ernst & Young's Global Biotechnology Report." This comprehensive report summarizes the sector's performance using key metrics – financial performance, financing, deals, and pipeline productivity. A panel discussion exploring the world of biotech in the time of the "new normal" will immediately follow the presentation of the report's findings.
Welcome:
Glen Giovannetti, Global Biotechnology Leader, Ernst & Young LLP
Moderator:
Christian Plaza, Partner-in-Charge, Boston Office; Cooley LLP
Panelists:
Peter Wirth, EVP Legal and Corporate Development; Secretary, Genzyme Corp.
Mark J. Pykett, CEO, Talaris Advisors
Michael Clayman, CEO, Flexion Therapeutics
Mark Levin, Managing Partner/Co-Founder, Third Rock Ventures
For more information or to register, please visit the event website.